Upperton Pharma Solutions, established in 1999, is a specialist CDMO (contract development and manufacturing organisation) headquartered in the United Kingdom. The company serves the biotechnology, industrial, and pharmaceutical industries with expertise in formulation and dosage form development, as well as clinical trial manufacturing services.
Recognized for its slogan, "Your Integrated CDMO Specialist. Driven by experts, led by science.", Upperton provides a comprehensive development service from early feasibility studies to clinical trial manufacturing. The company excels particularly in pharmaceutical spray drying, a leading technology known for its versatility.
With an extensive, multinational client base, Upperton prides itself on a flexible, client-focused approach and scientific excellence. Their last notable financial activity was a Private Equity Round on April 21, 2022, with backing from Inflexion Partners, indicating strong investor confidence in their growth and capabilities.